4//SEC Filing
Agah Ramtin 4
Accession 0001493152-22-017155
CIK 0001574094other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:06 PM ET
Size
9.1 KB
Accession
0001493152-22-017155
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Agah Ramtin
DirectorChief Medical Officer
Transactions
- Conversion
Convertible Notes
2021-08-30−1,295→ 0 total→ Common Stock (1,295 underlying) - Conversion
Common Stock
2021-08-30+1,295→ 976,295 total - Conversion
Warrants (right to buy)
2021-08-30+1,295→ 1,295 totalExercise: $10.80Exp: 2026-08-30→ Common Stock (1,295 underlying)
Footnotes (2)
- [F1]Upon the closing of the Issuer's initial public offering, each Convertible Note, plus accrued interest, automatically converted into (i) one share of common stock and (ii) one five-year warrant to purchase one share of common stock at an exercise price equal to $10.80 per share.
- [F2]The shares of Common Stock underlying the warrant are immediately exercisable.
Documents
Issuer
RenovoRx, Inc.
CIK 0001574094
Entity typeother
Related Parties
1- filerCIK 0001862617
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:06 PM ET
- Size
- 9.1 KB